A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells

Journal of Cellular Biochemistry

Volumn 117, Issue 1, 2016, Pages 94-105

  Wang, Liang ^a,b   Zhang, Xiaojing ^c   Chan, Judy Yuet Wa ^a   Shan, Luchen ^c   Cui, Guozhen ^a   Cui, Qingbin ^c   Wang, Yingfei ^c   Li, Jingjing ^a   Chen, Huanxian ^a   Zhang, Qingwen ^a   Yu, Pei ^c   Han, Yifan ^b   Wang, Yuqiang ^c   Lee, Simon Ming Yuen ^a  

^a UNIVERSITY OF MACAU   (Macao)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c JINAN UNIVERSITY   (China)

Author keywords

BREAST CANCER; CARDIOTOXICITY; DOXORUBICIN; MITOCHONDRIAL BIOGENESIS

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; CARDIAC AGENT; D 006; DOXORUBICIN; MITOCHONDRIAL DNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CASPASE 3;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; GENE DOSAGE; HEART DISEASE; HEART PROTECTION; HEART VENTRICLE FUNCTION; MITOCHONDRIAL BIOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; APOPTOSIS; BREAST TUMOR; CARDIAC MUSCLE CELL; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; MCF-7 CELL LINE; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING; ZEBRA FISH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; DOXORUBICIN; FEMALE; HUMANS; MCF-7 CELLS; MYOCYTES, CARDIAC; ZEBRAFISH;

EID: 84956688638     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25253     Document Type: Article

References (45)

1. Bouitbir J, Charles AL, Echaniz-Laguna A, Kindo M, Daussin F, Auwerx J, Piquard F, Geny B, Zoll J,. 2012. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: A 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. Eur Heart J 33: 1397-1407.
2. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ,. 2009. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-U105.
3. Cheng H, Kari G, Dicker AP, Rodeck U, Koch WJ, Force T,. 2011. A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity. Circ Res 109: 1401-1409.
4. Cui G, Shan L, Hung M, Lei S, Choi I, Zhang Z, Yu P, Hoi P, Wang Y, Lee SM,. 2013. A novel danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways. Int J Cardiol 168: 1349-1359.
5. Ding Y, Sun X, Huang W, Hoage T, Redfield M, Kushwaha S, Sivasubbu S, Lin X, Ekker S, Xu X,. 2011. Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish. Circ Res 109: 658-669.
6. Fan LH, Wang KZ, Cheng B, Wang CS, Dang XQ,. 2006. Anti-apoptotic and neuroprotective effects of tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci 7: 48.
7. Feenstra J, Grobbee DE, Remme WJ, Stricker BHC,. 1999. Drug-induced heart failure. J Am Coll Cardiol 33: 1152-1162.
8. Gharib MI, Burnett AK,. 2002. Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis. Eur J Heart Fail 4: 235-242.
9. Green PS, Leeuwenburgh C,. 2002. Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochim Biophys Acta 1588: 94-101.
10. Guo RM, Lin JC, Xu WM, Shen N, Mo LQ, Zhang CR, Feng JQ,. 2013a. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. Int J Mol Med 31: 644-650.
11. Guo RM, Wu K, Chen JF, Mo LQ, Hua XX, Zheng DD, Chen PX, Chen G, Xu WM, Feng JQ,. 2013b. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NF kappa B pathway in H9c2 cardiac cells. Cell Physiol Biochem 32: 1668-1680.
12. Guo J, Guo Q, Fang H, Lei L, Zhang T, Zhao J, Peng S,. 2014. Cardioprotection against doxorubicin by metallothionein is associated with preservation of mitochondrial biogenesis involving PGC-1alpha pathway. Eur J Pharmacol 737: 117-124.
13. Hamm EE, Voth DE, Ballard JD,. 2006. Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc Natl Acad Sci USA 103: 14176-14181.
14. Huang CJ, Tu CT, Hsiao CD, Hsieh FJ, Tsai HJ,. 2003. Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Dev Dyn 228: 30-40.
15. Huang W, Deng Y, Dong W, Yuan WZ, Wan YQ, Mo XY, Li YQ, Wang ZQ, Wang YQ, Ocorr K, Zhang B, Lin S, Wu XS,. 2011. The effect of excess expression of GFP in a novel heart-specific green fluorescence zebrafish regulated by nppa enhancer at early embryonic development. Mol Biol Rep 38: 793-799.
16. Ichikawa Y, Ghanefar M, Bayeva M, Wu RX, Khechaduri A, Prasad SVN, Mutharasan RK, Naik TJ, Ardehali H,. 2014. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest 124: 617-630.
17. Kim DS, Chae SW, Kim HR, Chae HJ,. 2009. CO and bilirubin inhibit doxorubicin-induced cardiac cell death. Immunopharmacol Immunotoxicol 31: 64-70.
18. Kong X, Fan H, Liu X, Wang R, Liang J, Gupta N, Chen Y, Fang F, Chang Y,. 2009. Peroxisome proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5'-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase. Mol Pharmacol 76: 854-860.
19. Li S, Shan L, Zhang Z, Li W, Liao K, Sheng X, Yu P, Wang Y,. 2015. Pharmacokinetic and metabolic studies of ADTM: A vovel Danshensu derivative confers cardioprotection by HPLC-UV and LC-MS/MS. J Chromatogr Sci 53: 872-878.
20. Li WM, Liu HT, Li XY, Wu JY, Xu G, Teng YZ, Ding ST, Yu C,. 2010. The effect of tetramethylpyrazine on hydrogen peroxide-induced oxidative damage in human umbilical vein endothelial cells. Basic Clin Pharmacol Toxicol 106: 45-52.
21. Liu C, Liu Z, Li M, Li X, Wong YS, Ngai SM, Zheng W, Zhang Y, Chen T,. 2013. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase. PLoS ONE 8: e53945.
22. Lv X, Yu X, Wang Y, Wang F, Li H, Lu D, Qi R, Wang H,. 2012. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS ONE 7: e47351.
23. Marutani E, Kosugi S, Tokuda K, Khatri A, Nguyen R, Atochin DN, Kida K, Van Leyen K, Arai K, Ichinose F,. 2012. A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death. J Biolog Chem 287: 32124-32135.
24. Misset JL, Dieras V, Gruia G, Bourgeois H, Cvitkovic E, Kalla S, Bozec L, Beuzeboc P, Jasmin C, Aussel JP, Riva A, Azli N, Pouillart P,. 1999. Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer. Ann Oncol 10: 553-560.
25. Miyagawa K, Emoto N, Widyantoro B, Nakayama K, Yagi K, Rikitake Y, Suzuki T, Hirata K,. 2010. Attenuation of Doxorubicin-induced cardiomyopathy by endothelin-converting enzyme-1 ablation through prevention of mitochondrial biogenesis impairment. Hypertension 55: 738-746.
26. Onishi Y, Ueha T, Kawamoto T, Hara H, Toda M, Harada R, Minoda M, Kurosaka M, Akisue T,. 2014. Regulation of mitochondrial proliferation by PGC-1alpha induces cellular apoptosis in musculoskeletal malignancies. Sci Rep 4: 3916.
27. Piantadosi CA, Carraway MS, Babiker A, Suliman HB,. 2008. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 103: 1232-U1260.
28. Riad A, Bien S, Westermann D, Becher PM, Loya K, Landmesser U, Kroemer HK, Schultheiss HP, Tschope C,. 2009. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice. Cancer Res 69: 695-699.
29. Sawyer DB,. 2013. Anthracyclines and heart failure. N Engl J Med 368: 1154-1156.
30. Sharma J, Johnston MV, Hossain MA,. 2014. Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation. BMC Neurosci 15: 9.
31. Skildum A, Dornfeld K, Wallace K,. 2011. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance. Breast Cancer Res Treat 129: 785-797.
32. Suliman HB, Carraway MS, Ali AS, Reynolds CM, Welty-Wolf KE, Piantadosi CA,. 2007a. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 117: 3730-3741.
33. Suliman HB, Carraway MS, Tatro LG, Piantadosi CA,. 2007b. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 120: 299-308.
34. Sun J, Sun G, Meng X, Wang H, Luo Y, Qin M, Ma B, Wang M, Cai D, Guo P, Sun X,. 2013a. Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. PLoS ONE 8: e64526.
35. Sun L, Zhao M, Yu XJ, Wang H, He X, Liu JK, Zang WJ,. 2013b. Cardioprotection by acetylcholine: A novel mechanism via mitochondrial biogenesis and function involving the PGC-1alpha pathway. J Cell Physiol 228: 1238-1248.
36. Swain SM, Vici P,. 2004. The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: Expert panel review. J Cancer Res Clin Oncol 130: 1-7.
37. Swain SM, Whaley FS, Ewer MS,. 2003. Congestive heart failure in patients treated with doxorubicin-A retrospective analysis of three trials. Cancer 97: 2869-2879.
38. Tang JY, Li S, Li ZH, Zhang ZJ, Hu GA, Cheang LCV, Alex D, Hoi MPM, Kwan YW, Chan SW, Leung GPH, Lee SMY,. 2010. Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC. PloS ONE 5: e11822.
39. Von Hoff DD, Layard MW, Basa P, Davis HL, Jr., Von Hoff AL, Rozencweig M, Muggia FM,. 1979. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91: 710-717.
40. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B,. 2004. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways. J Biol Chem 279: 25535-25543.
41. Wareski P, Vaarmann A, Choubey V, Safiulina D, Liiv J, Kuum M, Kaasik A,. 2009. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons. J Biol Chem 284: 21379-21385.
42. Yin Y, Guan Y, Duan J, Wei G, Zhu Y, Quan W, Guo C, Zhou D, Wang Y, Xi M, Wen A,. 2013. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol 699: 219-226.
43. Zhang Y, Ba Y, Liu C, Sun G, Ding L, Gao S, Hao J, Yu Z, Zhang J, Zen K, Tong Z, Xiang Y, Zhang CY,. 2007. PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. Cell Res 17: 363-373.
44. Zhang YY, Wang CG, Huang LX, Chen R, Chen YX, Zuo ZH,. 2012. Low-level pyrene exposure causes cardiac toxicity in zebrafish (Danio rerio) embryos. Aquat Toxicol 114: 119-124.
45. Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB,. 2001. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Can Res 61: 771-777.